Mira1a Therapeutics, Inc. [Rocket]

Overview

Mira1a Therapeutics, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/12/2023	3	Form 3 - Initial statement of beneficial ownership of securities:
10/12/2023	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/24/2023	4	Cappy George (10% Owner) has filed a Form 4 on MIRA PHARMACEUTICALS, INC.
08/21/2023	4	Nicholoudis Christos (Director) has filed a Form 4 on MIRA PHARMACEUTICALS, INC.
08/21/2023	4	Yanez Michelle (CFO, Secretary and Treasurer) has filed a Form 4 on MIRA PHARMACEUTICALS, INC.
08/21/2023	4	Chapman Christopher C JR (Executive Chairman) has filed a Form 4 on MIRA PHARMACEUTICALS, INC.
08/21/2023	4	Aminov Erez (CEO and Director) has filed a Form 4 on MIRA PHARMACEUTICALS, INC.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21
Revenues	0.0	0.0
Cost of goods sold	7.0	2.2
Gross profit	-7.0	-2.2
Research and development	2.4	0.7
General and administrative	3.0	0.8
EBIT	-7.0	-2.2
Pre-tax income	-7.1	-2.2
Income taxes	0.0	0.0
Tax rate	0.0%	0.0%
Net income	-7.1	-2.2


EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy